FAQ

Rotavirus Vaccines

Known as: Rotavirus Vaccines [Chemical/Ingredient], rotavirus, unspecified formulation, Rotavirus Vaccine, Live, Oral 
A viral vaccine that prevents against rotavirus infection, the leading cause of severe acute gastroenteritis.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1978-2018
05010019782018

Related topics

Related topics

12 relations
Attenuated Live Virus VaccineIn BloodProcess of secretionagonists
(More)

Narrower (3)

RIT 4237 vaccineRotaTeqrhesus rotavirus vaccine

Broader (1)

Viral Vaccines

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
Rotavirus Vaccines
In Blood
chemical synthesis
Viral Vaccines
standards characteristics
Process of secretion

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.
INTRODUCTION : Rotavirus vaccines were introduced into the funded Australian National Immunization Program (NIP) in July 2007… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Effect of human rotavirus vaccine on severe diarrhea in African infants.
BACKGROUND Rotavirus is the most common cause of severe gastroenteritis among young children worldwide. Data are needed to assess… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial.
BACKGROUND Rotavirus gastroenteritis causes many deaths in infants in sub-Saharan Africa. Because rotavirus vaccines have proven… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial.
BACKGROUND Rotavirus vaccine has proved effective for prevention of severe rotavirus gastroenteritis in infants in developed… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Effect of rotavirus vaccination on death from childhood diarrhea in Mexico.
BACKGROUND A phased introduction of a monovalent rotavirus vaccine occurred in Mexico from February 2006 through May 2007. We… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua.
CONTEXT Pentavalent rotavirus vaccine (RV5), a live, oral attenuated vaccine, prevented 98% of severe rotavirus diarrhea in a… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind…
BACKGROUND Peak incidence of rotavirus gastroenteritis is seen in infants between 6 and 24 months of age. We therefore aimed to… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study.
BACKGROUND We aimed to assess the efficacy of the oral live attenuated human rotavirus vaccine Rotarix (RIX4414) for prevention… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.
BACKGROUND Rotavirus is a leading cause of childhood gastroenteritis and death worldwide. METHODS We studied healthy infants… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
In February 2006, a live, oral, human-bovine reassortant rotavirus vaccine (RotaTeq) was licensed for use among U.S. infants. The… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?